Annual EBITDA
-$6.30M$134.07M-104.93%
Summary
- Current Value
- As of today, RGEN annual EBITDA is -$6.30M, down -104.93% on
- Historical Performance
- RGEN annual EBITDA is down -103.10% over the past 3 years, and down -111.19% over the past 5 years
- All-Time High Comparison
- RGEN annual EBITDA is currently -102.32% below its historical high of $271.29M set on
- 3-Year Low Comparison
- RGEN annual EBITDA is at its 3-year low
- Sector Comparison
- RGEN annual EBITDA is higher than 66.53% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$6.30M | -104.9% | -103.1% | -111.2% | -79.2% | |
| Quarterly EBITDA | $36.36M | +111.7% | -52.6% | +26.8% | +3794.0% | |
| TTM EBITDA | $158.18M | +35.8% | -46.4% | +86.3% | +10000.0% | |
| Price | $166.82 | +7.8% | +5.0% | -19.9% | +3717.4% | |
| PE Ratio | 6,465.89 | – | +10000.0% | +3352.7% | +1379.6% | |
| Annual Revenue | $634.44M | +0.3% | -5.4% | +134.8% | +2925.3% | |
| Annual EPS | -$0.46 | -172.2% | -120.4% | -204.8% | -250.8% | |
| Annual EBIT | -$6.30M | -110.7% | -103.8% | -117.8% | -28.7% | |
| Annual Net Income | -$25.51M | -171.7% | -119.9% | -219.2% | -527.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $271.29M | N/A | -102.3% |
| 5Y | $271.29M | -102.3% | |
| All | $271.29M | -102.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$6.30M | at low | |
| 5Y | -$6.30M | at low | |
| All | -$17.70M | +64.4% |
EBITDA History
FAQ
What is the current annual EBITDA of RGEN?
As of today, RGEN annual EBITDA is -$6.30M
What is 1-year change in RGEN annual EBITDA?
RGEN annual EBITDA is down -104.93% year-over-year
What is 3-year change in RGEN annual EBITDA?
RGEN annual EBITDA is down -103.10% over the past 3 years
How far is RGEN annual EBITDA from its all-time high?
RGEN annual EBITDA is currently -102.32% below its historical high of $271.29M set on December 31, 2022
How does RGEN annual EBITDA rank versus sector peers?
RGEN annual EBITDA is higher than 66.53% of companies in Healthcare sector
When is RGEN next annual earnings release?
The next annual earnings release for RGEN is on
Quarterly EBITDA
$36.36M$6.83M-15.81%
Summary
- Current Value
- As of today, RGEN quarterly EBITDA is $36.36M, down -15.81% on
- Historical Performance
- RGEN quarterly EBITDA is up +111.69% year-over-year, and down -52.58% over the past 3 years
- All-Time High Comparison
- RGEN quarterly EBITDA is currently -55.65% below its historical high of $81.98M set on
- 3-Year Low Comparison
- RGEN quarterly EBITDA is +111.69% above its 3-year low of $17.18M reached on
- Sector Comparison
- RGEN quarterly EBITDA is higher than 84.34% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $36.36M | -15.8% | +111.7% | -52.6% | +26.8% | |
| Annual EBITDA | -$6.30M | – | -104.9% | -103.1% | -111.2% | |
| TTM EBITDA | $158.18M | +13.8% | +35.8% | -46.4% | +86.3% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| PE Ratio | 6,465.89 | +12.1% | – | +10000.0% | +3352.7% | |
| Quarterly Revenue | $188.81M | +3.5% | +21.9% | -6.0% | +100.7% | |
| Quarterly EPS | $0.26 | +0.3% | +2354.7% | -62.6% | -3.1% | |
| Quarterly EBIT | $16.35M | +101.4% | +482.0% | -74.5% | -25.6% | |
| Quarterly Net Income | $14.91M | +0.3% | +2380.0% | -63.1% | +2.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $43.19M | -15.8% | |
| 3Y | $46.07M | N/A | -21.1% |
| 5Y | $81.98M | -55.6% | |
| All | $81.98M | -55.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $36.36M | at low | |
| 3Y | $17.18M | +111.7% | |
| 5Y | $17.18M | +111.7% | |
| All | -$10.90M | +433.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RGEN?
As of today, RGEN quarterly EBITDA is $36.36M
What is RGEN quarterly EBITDA most recent change?
RGEN quarterly EBITDA was down -15.81% on September 30, 2025
What is 1-year change in RGEN quarterly EBITDA?
RGEN quarterly EBITDA is up +111.69% year-over-year
How far is RGEN quarterly EBITDA from its all-time high?
RGEN quarterly EBITDA is currently -55.65% below its historical high of $81.98M set on June 30, 2022
How does RGEN quarterly EBITDA rank versus sector peers?
RGEN quarterly EBITDA is higher than 84.34% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
TTM EBITDA
$158.18M$19.18M+13.80%
Summary
- Current Value
- As of today, RGEN TTM EBITDA is $158.18M, up +13.80% on
- Historical Performance
- RGEN TTM EBITDA is up +35.82% year-over-year, and down -46.39% over the past 3 years
- All-Time High Comparison
- RGEN TTM EBITDA is currently -46.39% below its historical high of $295.06M set on
- 3-Year Low Comparison
- RGEN TTM EBITDA is +42.65% above its 3-year low of $110.89M reached on
- Sector Comparison
- RGEN TTM EBITDA is higher than 85.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $158.18M | +13.8% | +35.8% | -46.4% | +86.3% | |
| Annual EBITDA | -$6.30M | – | -104.9% | -103.1% | -111.2% | |
| Quarterly EBITDA | $36.36M | -15.8% | +111.7% | -52.6% | +26.8% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| PE Ratio | 6,465.89 | +12.1% | – | +10000.0% | +3352.7% | |
| TTM Revenue | $707.89M | +5.0% | +11.7% | -11.7% | +116.4% | |
| TTM EPS | $0.03 | +110.3% | +117.5% | -99.1% | -96.9% | |
| TTM EBIT | $48.29M | +74.6% | +73.8% | -80.5% | -18.6% | |
| TTM Net Income | $1.74M | +112.6% | +121.5% | -99.0% | -96.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $158.18M | at high | |
| 3Y | $280.44M | N/A | -43.6% |
| 5Y | $295.06M | -46.4% | |
| All | $295.06M | -46.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $110.89M | N/A | +42.6% |
| 3Y | $110.89M | +42.6% | |
| 5Y | $102.82M | N/A | +53.8% |
| All | -$19.30M | +919.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RGEN?
As of today, RGEN TTM EBITDA is $158.18M
What is RGEN TTM EBITDA most recent change?
RGEN TTM EBITDA was up +13.80% on September 30, 2025
What is 1-year change in RGEN TTM EBITDA?
RGEN TTM EBITDA is up +35.82% year-over-year
How far is RGEN TTM EBITDA from its all-time high?
RGEN TTM EBITDA is currently -46.39% below its historical high of $295.06M set on September 30, 2022
How does RGEN TTM EBITDA rank versus sector peers?
RGEN TTM EBITDA is higher than 85.61% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- RGEN Official Website www.repligen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/730272/000119312525252385/0001193125-25-252385-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000095017025038999/0000950170-25-038999-index.htm
- RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
- RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen